| Dr Arash Rezazadeh Kalebasty, MD | |
|
101 The City Dr S Bldg 23, Orange, CA 92868-3201 | |
| (714) 456-8000 | |
| Not Available |
| Full Name | Dr Arash Rezazadeh Kalebasty |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 35 Years |
| Location | 101 The City Dr S Bldg 23, Orange, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205974755 | NPI | - | NPPES |
| 000000525606 | Other | ANTHEM - NICC | |
| 200989910 | Medicaid | IN | |
| 7100129580 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 40927 (Kentucky) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | C167307 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of California Irvine Medical Center | Orange, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uc Regents | 7416869516 | 205 |
News Archive
Health experts have termed healthy living practices as the keep to longer life and self preservation. Although a lot of people spend days looking for wealth, prosperity and self fulfillment, all this means nothing if they can't keep their bodies healthy.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
Crittenton Children's Center has received a two-year, $10,000 grant from the Eye Movement Desensitization and Reprocessing Research Foundation to conduct a first of its kind study addressing trauma in children.
A web-based technology that helps pediatricians, parents and educators improve the quality of care for Attention-Deficit/Hyperactivity Disorder, is being offered for free to pediatric primary care practices nationwide by Cincinnati Children's Hospital Medical Center.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
› Verified 3 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760430847 PECOS PAC ID: 7416869516 Enrollment ID: O20031118000906 |
News Archive
Health experts have termed healthy living practices as the keep to longer life and self preservation. Although a lot of people spend days looking for wealth, prosperity and self fulfillment, all this means nothing if they can't keep their bodies healthy.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
Crittenton Children's Center has received a two-year, $10,000 grant from the Eye Movement Desensitization and Reprocessing Research Foundation to conduct a first of its kind study addressing trauma in children.
A web-based technology that helps pediatricians, parents and educators improve the quality of care for Attention-Deficit/Hyperactivity Disorder, is being offered for free to pediatric primary care practices nationwide by Cincinnati Children's Hospital Medical Center.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arash Rezazadeh Kalebasty, MD 200 S Manchester Ave Ste 300, Orange, CA 92868-3219 Ph: (714) 456-2986 | Dr Arash Rezazadeh Kalebasty, MD 101 The City Dr S Bldg 23, Orange, CA 92868-3201 Ph: (714) 456-8000 |
News Archive
Health experts have termed healthy living practices as the keep to longer life and self preservation. Although a lot of people spend days looking for wealth, prosperity and self fulfillment, all this means nothing if they can't keep their bodies healthy.
A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.
Crittenton Children's Center has received a two-year, $10,000 grant from the Eye Movement Desensitization and Reprocessing Research Foundation to conduct a first of its kind study addressing trauma in children.
A web-based technology that helps pediatricians, parents and educators improve the quality of care for Attention-Deficit/Hyperactivity Disorder, is being offered for free to pediatric primary care practices nationwide by Cincinnati Children's Hospital Medical Center.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
› Verified 3 days ago
Michael Cheng, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7110 | |
Harry Nguyen, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7002 | |
Millie Arora, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, City Tower, Suite 400, Orange, CA 92868 Phone: 714-456-5691 Fax: 714-456-8874 | |
Dr. Sarah Jeanette Ettinger, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5135 | |
Dr. Antonio Halais Frangieh, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Dr. Andy Yen-tang Lee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Dr. Jesse John Goitia Jr., M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |